410 filings
Page 2 of 21
6-K
xxwfqu5qg3k9ondl
17 Jul 24
SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million
9:25am
6-K
a88uujqdwyf10pc
16 Jul 24
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
4:35pm
6-K
hf4tpb48w9ktzk
16 Jul 24
SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss
9:25am
6-K
z71g1gi7uoe 8xx8yh1d
8 Jul 24
SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company
4:35pm
EFFECT
f9jtp
25 Jun 24
Notice of effectiveness
12:15am
POS AM
jw1xv89py
17 Jun 24
Prospectus update (post-effective amendment)
4:05pm
6-K
g24aet1i3q7 glo
14 Jun 24
Report of Foreign Private Issuer
4:00pm
6-K
mttmrhapmv
3 Jun 24
SciSparc Secures Strategic Advantage with Grant of European Patent
7:13am
POS AM
6zcemiibm 25lm61
2 May 24
Prospectus update (post-effective amendment)
5:17pm
425
iaoj 0porwkyp7zms37w
2 May 24
Business combination disclosure
4:46pm
6-K
992e0cx
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
20-F/A
jaj2e zoaxi
2 May 24
Annual report (foreign) (amended)
9:18am
425
xf0ujmn ti08u
12 Apr 24
Business combination disclosure
9:23am
6-K
4braaq
11 Apr 24
Agreement and Plan of Merger
4:05pm
S-8
kk6 za0tjis30
1 Apr 24
Registration of securities for employees
5:11pm
6-K
517pi
27 Mar 24
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
9:18am
6-K
ghhsdl3q dympi
15 Mar 24
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
8:00am
6-K
6suf57b4t6by1qz
13 Mar 24
Report of Foreign Private Issuer
9:06am
6-K
n1cmy
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am